Please enable JavaScript to continue using this application.

Compare $TNXP vs $TNYA | Chartloom

Compare

$TNXP vs $TNYA

Tonix Pharmaceuticals Holding Corp · Tenaya Therapeutics Inc

TNXP

Tonix Pharmaceuticals Holding Corp

TNYA

Tenaya Therapeutics Inc

Compare $TNXP vs $TNYA

Comparing Tonix Pharmaceuticals Holding Corp and Tenaya Therapeutics Inc

TNXPTonix Pharmaceuticals Holding Corp

TNYATenaya Therapeutics Inc

TNXPTonix Pharmaceuticals Holding Corp

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.39x

Rev growth (TTM)

196.0%

YTD performance

-55.9%

52W performance

-67.5%

FCF yield

-135.9%

TNYATenaya Therapeutics Inc

Market cap

$126M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

20.11x

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

-68.3%

FCF yield

-41.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TNXP

TNYA

Detailed metrics comparison

TNXP

Tonix Pharmaceuticals Holding Corp

TNYA

Tenaya Therapeutics Inc

Market Cap

TNXP$116M

TNYA$126M

Enterprise Value

TNXP$-60M

TNYA$48M

Price

TNXP$7.30

TNYA$0.58

P/E Ratio

TNXPN/A

TNYAN/A

P/S Ratio

TNXP4.00x

TNYA94.33x

EV/Sales

TNXP-2.06x

TNYA35.84x

EV/EBITDA

TNXP0.00x

TNYA0.00x

P/B Ratio

TNXP0.69x

TNYA1.82x

P/FCF Ratio

TNXPN/A

TNYAN/A

EV/FCF

TNXP0.38x

TNYA-0.91x

PEG Ratio

TNXPN/A

TNYAN/A

Forward P/E (NTM)

TNXPN/A

TNYAN/A

Forward P/S (NTM)

TNXP1.39x

TNYA20.11x

Revenue (TTM)

TNXP$29M

TNYA$1M

Revenue Growth (YoY)

TNXP196.0%

TNYAN/A

Forward Rev Growth

TNXP101.6%

TNYA-49.9%

Gross Margin (TTM)

TNXP83.8%

TNYA0.0%

Operating Margin (TTM)

TNXP0.0%

TNYA0.0%

EBITDA Margin (TTM)

TNXP-561.1%

TNYA-5657.2%

Net Margin (TTM)

TNXP-548.6%

TNYA-7724.0%

FCF Margin (TTM)

TNXP-543.3%

TNYA-3939.2%

Net Income (TTM)

TNXP$-160M

TNYA$-103M

FCF (TTM)

TNXP$-158M

TNYA$-53M

EPS (TTM)

TNXP-$9.60

TNYA-$0.47

ROE (TTM)

TNXP-6899.0%

TNYA-10805.0%

ROA (TTM)

TNXP-6132.0%

TNYA-8584.0%

ROIC (TTM)

TNXP-6899.0%

TNYA-10805.0%

Cash

TNXP$176M

TNYA$78M

Debt

TNXP$0

TNYA$0

Net Cash/Debt

TNXP$176M

TNYA$78M

Current Ratio (TTM)

TNXP6.61x

TNYA4.52x

Quick Ratio (TTM)

TNXP6.13x

TNYA4.34x

Debt/Equity (TTM)

TNXP0.00x

TNYA0.00x

Debt/Assets (TTM)

TNXP0.0%

TNYA0.0%

Interest Coverage (TTM)

TNXPN/A

TNYAN/A

Net Debt/EBITDA (TTM)

TNXP0.00x

TNYA0.00x

Beta

TNXP1.87

TNYA2.87

52W Performance

TNXP-67.5%

TNYA-68.3%

YTD Performance

TNXP-55.9%

TNYA-21.0%

% from 52W High

TNXP-68.3%

TNYA-75.3%

% from 52W Low

TNXP3.0%

TNYA11.4%

Asset Turnover (TTM)

TNXP0.11x

TNYA0.00x

FCF Yield (TTM)

TNXP-135.9%

TNYA-41.8%

Earnings Yield (TTM)

TNXP-137.2%

TNYA-81.9%

Dividend Yield (TTM)

TNXPN/A

TNYAN/A

Rule of 40

TNXP-347.3

TNYA-3,939.2

EV/GP/RG

TNXPN/A

TNYAN/A

Ticker research

View TNXP research View TNYA research

Metric	TNXP Tonix Pharmaceuticals Holding Corp	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$116M	$126M
Enterprise Value	$-60M	$48M
Price	$7.30	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	4.00x	94.33x
EV/Sales	-2.06x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.69x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	0.38x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.39x	20.11x
Revenue & Growth
Revenue (TTM)	$29M	$1M
Revenue Growth (YoY)	196.0%	N/A
Forward Rev Growth	101.6%	-49.9%
Profitability
Gross Margin (TTM)	83.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-561.1%	-5657.2%
Net Margin (TTM)	-548.6%	-7724.0%
FCF Margin (TTM)	-543.3%	-3939.2%
Net Income (TTM)	$-160M	$-103M
FCF (TTM)	$-158M	$-53M
EPS (TTM)	-$9.60	-$0.47
ROE (TTM)	-6899.0%	-10805.0%
ROA (TTM)	-6132.0%	-8584.0%
ROIC (TTM)	-6899.0%	-10805.0%
Financial Health
Cash	$176M	$78M
Debt	$0	$0
Net Cash/Debt	$176M	$78M
Current Ratio (TTM)	6.61x	4.52x
Quick Ratio (TTM)	6.13x	4.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.87	2.87
52W Performance	-67.5%	-68.3%
YTD Performance	-55.9%	-21.0%
% from 52W High	-68.3%	-75.3%
% from 52W Low	3.0%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-135.9%	-41.8%
Earnings Yield (TTM)	-137.2%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-347.3	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View TNXP research	View TNYA research

Valuation

P/S Ratio

TNXP

4.00x

TNYA

94.33x

EV/FCF

TNYA

-0.91x

TNXP

0.38x

Growth & revenue

Revenue Growth TTM

TNXP

196.0%

Forward Revenue Growth

TNXP

101.6%

TNYA

-49.9%

Profitability & performance

Gross Margin

TNXP

83.8%

TNYA

0.0%

ROE

TNXP

-6899.0%

TNYA

-10805.0%

FCF Yield %

TNYA

-41.8%

TNXP

-135.9%

52-Week Performance

TNXP

-67.5%

TNYA

-68.3%

Detailed metrics comparison

TNXP

Tonix Pharmaceuticals Holding Corp

TNYA

Tenaya Therapeutics Inc

Market Cap

TNXP$116M

TNYA$126M

Enterprise Value

TNXP$-60M

TNYA$48M

Price

TNXP$7.30

TNYA$0.58

P/E Ratio

TNXPN/A

TNYAN/A

P/S Ratio

TNXP4.00x

TNYA94.33x

EV/Sales

TNXP-2.06x

TNYA35.84x

EV/EBITDA

TNXP0.00x

TNYA0.00x

P/B Ratio

TNXP0.69x

TNYA1.82x

P/FCF Ratio

TNXPN/A

TNYAN/A

EV/FCF

TNXP0.38x

TNYA-0.91x

PEG Ratio

TNXPN/A

TNYAN/A

Forward P/E (NTM)

TNXPN/A

TNYAN/A

Forward P/S (NTM)

TNXP1.39x

TNYA20.11x

Revenue (TTM)

TNXP$29M

TNYA$1M

Revenue Growth (YoY)

TNXP196.0%

TNYAN/A

Forward Rev Growth

TNXP101.6%

TNYA-49.9%

Gross Margin (TTM)

TNXP83.8%

TNYA0.0%

Operating Margin (TTM)

TNXP0.0%

TNYA0.0%

EBITDA Margin (TTM)

TNXP-561.1%

TNYA-5657.2%

Net Margin (TTM)

TNXP-548.6%

TNYA-7724.0%

FCF Margin (TTM)

TNXP-543.3%

TNYA-3939.2%

Net Income (TTM)

TNXP$-160M

TNYA$-103M

FCF (TTM)

TNXP$-158M

TNYA$-53M

EPS (TTM)

TNXP-$9.60

TNYA-$0.47

ROE (TTM)

TNXP-6899.0%

TNYA-10805.0%

ROA (TTM)

TNXP-6132.0%

TNYA-8584.0%

ROIC (TTM)

TNXP-6899.0%

TNYA-10805.0%

Cash

TNXP$176M

TNYA$78M

Debt

TNXP$0

TNYA$0

Net Cash/Debt

TNXP$176M

TNYA$78M

Current Ratio (TTM)

TNXP6.61x

TNYA4.52x

Quick Ratio (TTM)

TNXP6.13x

TNYA4.34x

Debt/Equity (TTM)

TNXP0.00x

TNYA0.00x

Debt/Assets (TTM)

TNXP0.0%

TNYA0.0%

Interest Coverage (TTM)

TNXPN/A

TNYAN/A

Net Debt/EBITDA (TTM)

TNXP0.00x

TNYA0.00x

Beta

TNXP1.87

TNYA2.87

52W Performance

TNXP-67.5%

TNYA-68.3%

YTD Performance

TNXP-55.9%

TNYA-21.0%

% from 52W High

TNXP-68.3%

TNYA-75.3%

% from 52W Low

TNXP3.0%

TNYA11.4%

Asset Turnover (TTM)

TNXP0.11x

TNYA0.00x

FCF Yield (TTM)

TNXP-135.9%

TNYA-41.8%

Earnings Yield (TTM)

TNXP-137.2%

TNYA-81.9%

Dividend Yield (TTM)

TNXPN/A

TNYAN/A

Rule of 40

TNXP-347.3

TNYA-3,939.2

EV/GP/RG

TNXPN/A

TNYAN/A

Ticker research

View TNXP research View TNYA research

Metric	TNXP Tonix Pharmaceuticals Holding Corp	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$116M	$126M
Enterprise Value	$-60M	$48M
Price	$7.30	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	4.00x	94.33x
EV/Sales	-2.06x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.69x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	0.38x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.39x	20.11x
Revenue & Growth
Revenue (TTM)	$29M	$1M
Revenue Growth (YoY)	196.0%	N/A
Forward Rev Growth	101.6%	-49.9%
Profitability
Gross Margin (TTM)	83.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-561.1%	-5657.2%
Net Margin (TTM)	-548.6%	-7724.0%
FCF Margin (TTM)	-543.3%	-3939.2%
Net Income (TTM)	$-160M	$-103M
FCF (TTM)	$-158M	$-53M
EPS (TTM)	-$9.60	-$0.47
ROE (TTM)	-6899.0%	-10805.0%
ROA (TTM)	-6132.0%	-8584.0%
ROIC (TTM)	-6899.0%	-10805.0%
Financial Health
Cash	$176M	$78M
Debt	$0	$0
Net Cash/Debt	$176M	$78M
Current Ratio (TTM)	6.61x	4.52x
Quick Ratio (TTM)	6.13x	4.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.87	2.87
52W Performance	-67.5%	-68.3%
YTD Performance	-55.9%	-21.0%
% from 52W High	-68.3%	-75.3%
% from 52W Low	3.0%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-135.9%	-41.8%
Earnings Yield (TTM)	-137.2%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-347.3	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View TNXP research	View TNYA research